Navigation Links
Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
Date:6/13/2008

ook for, our operations, research development and product and drug development. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Many such risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and include, among others, the following: general economic and business conditions, both nationally and in the regions in which we operate; market demand; technological changes that could impact our existing products or our ability to develop and commercialize future products; competition; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; adverse results or unexpected delays in drug discovery and clinical development processes; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the requirement for substantial funding to conduct research and development, to expand commercialization activities or consummate acquisitions or to service or repay debt obligations; the accuracy of our estimations of the size of the market, and the potential market, for our products in specific disease areas; sales numbers and future guidance publicly provided by Boston Scientific Corporation regarding sales of their paclitaxel-eluting coronary stent products; and any other factors that may affect performance. In addition, our business is subject to certain operating risks that may cause the actual results expressed or implied by the forward-looking statements in this report to differ materially from our actual results. These operating risks include: our ability to attract and retain qualified personnel; our ability to successfully complete preclinical and clin
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
2. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
3. Angiotech appoints Hank McKinnell to its Board of Directors
4. Angiotech to participate in Bank of America Health Care Conference
5. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
6. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
7. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
9. Angiotech announces director resignation
10. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
11. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands ... His Majesty Willem-Alexander, King of the Netherlands, has announced ... POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in ... will take part in the Grand Opening Ceremony to ... p.m. and tour the plant. POET-DSM is a joint ...
(Date:8/21/2014)... Aug. 21, 2014 OTC Markets ... Inc., a biotechnology company, on its approval to ... traded on OTCQX®, the best marketplace for established ... Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... successful execution of its growth strategy and achievement ...
(Date:8/21/2014)... August 21, 2014 Gallus ... contract development and manufacturing organization (CMO) announced today ... Inc., an oncology company focused on the development ... to manufacture the anti-prostate specific membrane antigen (PSMA) ... candidate. Under the agreement the antibody will ...
(Date:8/20/2014)... it that American Indians largely were wiped out by ... tuberculosis brought to the New World by European explorers., ... people lived in the Americas shortly before Europeans arrived, ... European diseases., But new research led by anthropological geneticists ... of the University of Tubingen in Germany indicates the ...
Breaking Biology Technology:His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3
... Inc., a private clinical-stage biotherapeutics company focused on the ... cancer, today announced that key data from its Phase ... along with data from other JX-594 clinical trials, will ... Cell Therapy (ASGCT) Annual Meeting taking place May 18-21, ...
... Reportlinker.com announces that a new market research ... Industrial Biotechnology China News 1104 ... the regional turbulence in Egypt and Libya areas, ... at USD102 per barrel on March 2, 2011; ...
... SHENYANG, China, May 11, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ... a leading China-based biotechnology company focused on researching, developing, ... financial results for the first quarter ended March 31, ... Financial Highlights: Total net ...
Cached Biology Technology:Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 2Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 3Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 4Reportlinker Adds Industrial Biotechnology China News 1104 2Reportlinker Adds Industrial Biotechnology China News 1104 33SBio Inc. Announces Unaudited First Quarter 2011 Results 23SBio Inc. Announces Unaudited First Quarter 2011 Results 33SBio Inc. Announces Unaudited First Quarter 2011 Results 43SBio Inc. Announces Unaudited First Quarter 2011 Results 53SBio Inc. Announces Unaudited First Quarter 2011 Results 63SBio Inc. Announces Unaudited First Quarter 2011 Results 73SBio Inc. Announces Unaudited First Quarter 2011 Results 83SBio Inc. Announces Unaudited First Quarter 2011 Results 93SBio Inc. Announces Unaudited First Quarter 2011 Results 103SBio Inc. Announces Unaudited First Quarter 2011 Results 113SBio Inc. Announces Unaudited First Quarter 2011 Results 123SBio Inc. Announces Unaudited First Quarter 2011 Results 13
(Date:8/22/2014)... release is available in German . ... substances, in PCFs proteins are fixated in a way ... crystals. Next, the HZB and Fudan University researchers are ... as functional materials. Their findings are being published today ... 10.1038/ncomms5634). , Proteins are sensitive molecules. Everyone knows that ...
(Date:8/22/2014)... rhino reproduction in Europe highlights how hormone analysis ... Researchers from Chester Zoo, The University of Manchester ... six-year study which encompassed 90% of European population ... the research as part of her PhD at ... black rhinoceros breed well in captivity, not all ...
(Date:8/22/2014)... and can reduce free radical damage. Can ... stress? Jianbo Zhao and co-workers from the ... China discovered that green tea polyphenol effectively ... indicating green tea polyphenols play a protective ... stress. The relevant study has been published ...
Breaking Biology News(10 mins):Proteins: New class of materials discovered 2Hormone analysis helps identify horny rhinos 2
... Research (LICR) and the University of California, San Diego ... identifying functional elements in the human genome, according to ... , While the DNA sequence can identify genes (the ... fundamental questions of 'how,' 'when' and 'where' gene products ...
... be caused by hypoglycemic coma actually occurs when glucose is ... rodents led by researchers at the San Francisco VA Medical ... and may be of clinical significance for the treatment of ... cannot be immediately extrapolated to humans. , Insulin is ...
... over a scientific paper that is putting Korea's scientific ... pitted a young Korean doctor, Jeong Hwan Kim, against ... the most powerful players in the country's struggle for ... threatening to disrupt Korea's efforts to recover scientific credibility ...
Cached Biology News:Beyond the DNA: Chemical signatures reveal genetic switches in the genome 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3Row over study puts Korea's scientific community under scrutiny again 2
Mouse Cell Line Slides...
Mouse Cell Line Slides...
Request Info...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
Biology Products: